kabutan

CHUGAI PHARMA, Jan-Mar (1Q) Net Income Increases by 31%

Thu Apr 24, 2025 5:00 pm JST Earnings

4519 CHUGAI PHARMACEUTICAL CO., LTD. 【IFRS】

Earnings Report

CHUGAI PHARMACEUTICAL CO., LTD. <4519> [TSE Prime] announced its financial results (based on IFRS) after the market closed on April 24th (17:00). The consolidated net income for the first quarter of the fiscal year ending December 2025 (January to March) expanded 97.2 billion yen, an increase 30.7% compared to the same period last year.

In the most recent three-month period, from January to March (1Q), the operating profit margin rose from 42.1% in the same period last year to 47.4%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Mar, 2023 312,240 98,296 99,662 73,500 44.7 46.6 Apr 27, 2023 IFRS
Jan - Mar, 2024 236,949 99,874 99,889 74,401 45.2 38.6 Apr 24, 2024 IFRS
Jan - Mar, 2025 288,459 136,651 135,829 97,234 59.1 Apr 24, 2025 IFRS
YoY +21.7% +36.8% +36.0% +30.7% +30.7%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 552,860 258,195 258,690 186,262 113.2 41 Jul 25, 2024 IFRS
Jan - Jun, 2025 Guidance 125 Jan 30, 2025 IFRS
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,111,367 439,174 443,821 325,472 197.8 80 Feb 1, 2024 IFRS
Dec, 2024 1,170,611 542,002 543,034 387,317 235.4 98 Jan 30, 2025 IFRS
Dec, 2025 Guidance 1,190,000 250 Jan 30, 2025 IFRS
YoY +1.7%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 236,949 99,874 99,889 74,401 45.2 42.1 Apr 24, 2024 IFRS
Apr - Jun, 2024 315,911 158,321 158,801 111,861 68.0 50.1 Jul 25, 2024 IFRS
Jul - Sep, 2024 315,678 160,407 158,837 109,496 66.6 50.8 Oct 25, 2024 IFRS
Oct - Dec, 2024 302,073 123,400 125,507 91,559 55.6 40.9 Jan 30, 2025 IFRS
Jan - Mar, 2025 288,459 136,651 135,829 97,234 59.1 47.4 Apr 24, 2025 IFRS
YoY +21.7% +36.8% +36.0% +30.7% +30.7%

Related Articles